Related Experiment Video
Updated: Jan 5, 2026

Analysis of Translation Initiation During Stress Conditions by Polysome Profiling
Published on: May 19, 2014
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress
Annalisa Pecoraro1, Pietro Carotenuto2, Giulia Russo3
1Department of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131, Naples, Italy.
Abstract:
Several experimental strategies in the treatment of cancer include drug alteration of cell cycle regulatory pathways as a useful strategy. Extra-ribosomal functions of human ribosomal protein L3 (uL3) may affect DNA repair, cell cycle arrest and apoptosis. In the present study, we demonstrated that uL3 is required for the activation of G1/S transition genes. Luciferase assays established that uL3 negatively regulates the activity of E2F1 promoter. Induced ribosome-free uL3 reduces Cyclin D1 mRNA and protein levels. Using protein/protein immunoprecipitation methods, we demonstrated that uL3 physically interacts with PARP-1 affecting E2F1 transcriptional activity. Our findings led to the identification of a new pathway mediated by uL3 involving E2F1 and Cyclin D1 in the regulation of cell cycle progression.
Insights
Human ribosomal protein L3 (uL3) regulates cell cycle progression by affecting G1/S transition genes. This study reveals a new pathway involving uL3, E2F1, and Cyclin D1 in cancer treatment strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- Cancer treatment strategies often target cell cycle regulation.
- Extra-ribosomal functions of human ribosomal protein L3 (uL3) are implicated in DNA repair, cell cycle arrest, and apoptosis.
Purpose of the Study:
- To investigate the role of uL3 in regulating cell cycle progression.
- To identify the molecular mechanisms by which uL3 influences cell cycle genes.
Main Methods:
- Luciferase assays to assess E2F1 promoter activity.
- Western blotting to measure Cyclin D1 mRNA and protein levels.
- Co-immunoprecipitation to detect protein-protein interactions between uL3 and PARP-1.
Main Results:
- uL3 is essential for the activation of G1/S transition genes.
- uL3 negatively regulates E2F1 promoter activity.
- uL3 interacts with PARP-1, impacting E2F1 transcriptional activity and reducing Cyclin D1 levels.
Conclusions:
- A novel pathway mediated by uL3, involving E2F1 and Cyclin D1, regulates cell cycle progression.
- uL3's extra-ribosomal functions present a potential new therapeutic target in cancer treatment.
Related Concept Videos
Negative Regulator Molecules
The Nucleolus
Regulation of the Unfolded Protein Response
Stringent Response in E. coli
The Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

